Takeda, Japan's largest drug maker, plans to buy out Abbott's stake in their 50-50 U.S. joint venture, TAP, for 500 billion yen ($5 billion), a source close to the deal said on Wednesday.
Reuters
Now what might Abbott want the cash for? What with all the pharma companies trading at near 52 week lows an' all.
Reuters
Now what might Abbott want the cash for? What with all the pharma companies trading at near 52 week lows an' all.
No comments:
Post a Comment